Xu et al. [84] collected genomic data from pancreatic cancer tissues and constructed NAT10 subgroup phenotypes to assess the association between NAT10 levels and clinicopathological characteristics of patients with pancreatic cancer. The gene discussed is NAT10; the disease is pancreatic neoplasm.